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New approaches and targets in psychiatry neuroplastic changes precede chronic 
antidepressant responses of the 5-HT4 receptor agonist RS67333 
 
It has been recently suggested that activation of 5-HT4 receptors might possess 
antidepressant properties in rats after a 3 days treatment, indicating a new strategy for 
developing faster-acting antidepressants. In this regard, here we have evaluated in rat 
brain the expression of proteins related to neuroplasticity after a subacute RS67333 
treatment and their correlate on behavioural paradigms. A 3-days treatment with RS67333 
(1.5 mg/kg/day), previously shown to increase neurogenesis in dentate gyrus, induced an 
upregulation in the expression of BDNF (% increase = 64%; p < 0.05) and pCREB/CREB 
ratio (% increase = 93%; p < 0.01) in the hippocampus. A significant reduction in the 
forced swimming test (immobility time) was also observed after 3 (% red= 27%; p < 0.001) 
and 7 (% red=29%; P < 0.001) days of treatment. However, in the novelty-feeding 
suppressed test, a validated paradigm to predict chronic antidepressant efficacy, a 
significant reduction in the latency to feed (% red= 49%; p < 0.03) was observed only after 
7 days of treatment. Short-term treatment with RS67333 also failed to downregulate 5-HT4 
receptor-coupled adenylate cyclase activity. Our data suggest that neural proliferation-
related changes induced by antidepressants precede clinical improvement. Furthermore, 
when compared to data regarding classical antidepressants, our results show that the 
activation of 5-HT4 receptors could represent a good strategy for developing 
antidepressants with a minor onset of action. 
 
